Literature DB >> 24041364

Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force.

Pepijn Vemer1, George A K van Voom, Isaac Corro Ramos, Corro Ramos, Paul F M Krabbe, P F M Krabbe, Maiwenn J Al, M J Al, Talitha L Feenstra, T L Feenstra.   

Abstract

Mesh：

Year:  2013        PMID： 24041364     DOI： 10.1016/j.jval.2013.06.015

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  6 in total

1.  Four Aspects Affecting Health Economic Decision Models and Their Validation.

Authors:  Talitha Feenstra; Isaac Corro-Ramos; Dominique Hamerlijnck; George van Voorn; Salah Ghabri
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981

2.  GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

Authors:  Jan L Brozek; Carlos Canelo-Aybar; Elie A Akl; James M Bowen; John Bucher; Weihsueh A Chiu; Mark Cronin; Benjamin Djulbegovic; Maicon Falavigna; Gordon H Guyatt; Ami A Gordon; Michele Hilton Boon; Raymond C W Hutubessy; Manuela A Joore; Vittal Katikireddi; Judy LaKind; Miranda Langendam; Veena Manja; Kristen Magnuson; Alexander G Mathioudakis; Joerg Meerpohl; Dominik Mertz; Roman Mezencev; Rebecca Morgan; Gian Paolo Morgano; Reem Mustafa; Martin O'Flaherty; Grace Patlewicz; John J Riva; Margarita Posso; Andrew Rooney; Paul M Schlosser; Lisa Schwartz; Ian Shemilt; Jean-Eric Tarride; Kristina A Thayer; Katya Tsaioun; Luke Vale; John Wambaugh; Jessica Wignall; Ashley Williams; Feng Xie; Yuan Zhang; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2020-09-24       Impact factor: 6.437

3.  The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Authors:  Seamus Kent; Frauke Becker; Talitha Feenstra; An Tran-Duy; Iryna Schlackow; Michelle Tew; Ping Zhang; Wen Ye; Shi Lizheng; William Herman; Phil McEwan; Wendelin Schramm; Alastair Gray; Jose Leal; Mark Lamotte; Michael Willis; Andrew J Palmer; Philip Clarke
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

4.  The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling.

Authors:  George A K van Voorn; Pepijn Vemer; Dominique Hamerlijnck; Isaac Corro Ramos; Geertruida J Teunissen; Maiwenn Al; Talitha L Feenstra
Journal:  Appl Health Econ Health Policy       Date:  2016-04       Impact factor: 2.561

5.  AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

Authors:  P Vemer; I Corro Ramos; G A K van Voorn; M J Al; T L Feenstra
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

Review 6.  Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

Authors:  Pieter T de Boer; Geert W J Frederix; Talitha L Feenstra; Pepijn Vemer
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.